Lethal vascular leak syndrome after denileukin diftitox administration to a patient with cutaneous gamma/delta T‐cell lymphoma and occult cirrhosis-Reference-Cited by-同舟云学术

Lethal vascular leak syndrome after denileukin diftitox administration to a patient with cutaneous gamma/delta T‐cell lymphoma and occult cirrhosis

Published:2008-07 Issue:7 Volume:83 Page:593-595
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Avarbock Andrew B.,Loren Alison W.,Park Jason Y.,Junkins‐Hopkins Jacqueline M.,Choi John,Litzky Leslie A.,Rook Alain H.

Publisher

Wiley

Subject

Hematology

Reference25 articles.

1. Phase I trial of an interleukin‐2 (IL‐2) fusion toxin (DAB486IL‐2) in hematologic malignancies expressing the IL‐2 receptor;LeMaistre;Blood,1992

2. Phase II study of denileukin diftitox for relapsed/refractory B‐Cell non‐Hodgkin's lymphoma;Dang;J Clin Oncol,2004

3. Phase II trial of denileukin diftitox for relapsed/refractory T‐cell non‐Hodgkin lymphoma;Dang;Br J Haematol,2007

4. A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine‐refractory chronic lymphocytic leukemia;Frankel;Clin Cancer Res,2003

5. Denileukin diftitox for the treatment of steroid‐resistant acute graft‐versus‐host disease;Shaughnessy;Biol Blood Marrow Transplant,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Biological Properties of Bacterial Toxins;Journal of NBC Protection Corps;2024-06-17

2. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations;Leukemia & Lymphoma;2024-02-23

3. Harnessing the immune system in the treatment of cutaneous T cell lymphomas;Frontiers in Oncology;2023-01-12

4. Inhibition of FOXP3 by stapled alpha-helical peptides dampens regulatory T cell function;Proceedings of the National Academy of Sciences;2022-10-13

5. Bacterial Cancer Therapy: Promising Role in the Treatment of Colon Cancer;Colon Cancer Diagnosis and Therapy Vol. 3;2022